| Nov 14 |
AEON Biopharma GAAP EPS of -$0.16
|
| Nov 13 |
AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
|
| Aug 19 |
AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024
|
| Aug 13 |
AEON Biopharma reports Q2 results
|
| Jul 16 |
Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
|
| Jul 9 |
AEON Biopharma announces strategic reprioritization for ABP-450
|
| Jul 9 |
AEON Biopharma Announces Strategic Reprioritization to Pursue a Biosimilar Pathway for ABP-450
|
| May 29 |
Down -64.16% in 4 Weeks, Here's Why AEON Biopharma, Inc. (AEON) Looks Ripe for a Turnaround
|
| May 29 |
AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan
|
